We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
XTRA:4AB
​
​
logo

AbbVie Inc. (4AB)

XTRA • 4AB • US00287Y1091

Ex-dividend 15 Jan 27 · 1.82 USD (special)
252.50Last close
Market Closed
Ex-dividend 15 Jan 27 · 1.82 USD (special)
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 21, 2026, ORTEX estimated 0.1% of free float sold short, 1,342.6 days to cover, cost to borrow 0.44%. Sign up for live short interest data.

Market Cap

521b USD | # 24 in DE

Volume

587 shares | 180.9k USD

Shares Outstanding

1.77b

Free Float Shares

99.82% | 1.76b

NYSE:ABBV|
DB:4AB|
DB:4AB0|
LSE:0QCV|
TSX:ABBV|
BOVESPA:ABBV34|
BIT:1ABBV|
BASE:ABBV|
BASE:ABBV|
BASE:ABBVD|
WBAG:ABBV|
SET:ABBV19|
SET:ABBV80

News

4AB key data

AbbVie Inc. (XTRA: 4AB) has a market capitalization of $521.15B. Last close €252.50 (as of 2026-11-05); 52-week range €162.85 to €270.70. ORTEX data as of 2026-10-21: short interest was 0.07% of free float, 1,342.6 days to cover and the average cost to borrow was 0.44%. Sign up for live short interest data.

  • 4AB news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.